510(k) K954807
K954807 is an FDA 510(k) premarket notification submitted by Boehringer Mannheim Corp. for the device "CEDIA T UPTAKE ASSAY". The FDA issued a decision of Substantially Equivalent on December 21, 1995. The device falls under product code KHQ (Radioassay, Triiodothyronine Uptake), a Class II device regulated under 21 CFR 862.1715. Boehringer Mannheim Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 21, 1995
- Date Received
- October 19, 1995
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioassay, Triiodothyronine Uptake
- Device Class
- Class II
- Regulation Number
- 862.1715
- Review Panel
- CH
- Submission Type